Blood · 1993 · 82 citations · 27 references
MedicineHematologyImmunologyAutoimmunityClinical ImmunologyImmunopathologyAutoantibodiesAutoantigensPlatelet ActivationPlatelet DisordersPlatelet FunctionPlatelet PhysiologyAutoantibody PathogenesisAutoimmune ThrombocytopeniaImmune-mediated ThrombocytopeniaPlatelet Autoantibodies
Chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder due to autoantibody-induced destruction of platelets. Several forms of therapy have been used, including corticosteroids, splenectomy, danazol, and a variety of immunosuppressants. We studied the mechanism of action of some of these treatments by evaluating patients' platelet-associated autoantibodies (PAAb) and platelet count before and serially following therapy. Treatment with corticosteroids, splenectomy, cyclophosphamide, and combination chemotherapy resulted in a progressive decrease in PAAb associated with an improvement in the platelet count, and appeared to act by primarily affecting autoantibody production. Conversely, PAAb levels either remained stable or increased during vincristine or danazol therapy despite improvement in the platelet count, suggesting that the major effect of these agents was decreased platelet removal by the reticuloendothelial (RE) system.
27
Penny Ballem, Gerald M. Segal, Jon Stratton et al. · Journal of Clinical Investigation · 1987 · 401 citations · Full text
Medicine, Hematology, Pathology +12
N. Raphael Shulman, Victor J. Marder, Roy S. Weinrach · Annals of the New York Academy of Sciences · 1965 · 343 citations
Medicine, Hematology, Pathology +12
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP
Robert McMillan, P Tani, Frederick Millard et al. · Blood · 1987 · 314 citations · Full text